Shareholding ratio of shareholders after the merger of Aethlon Medical and North Immunology
2026-09-17 18:33:15
According to CoinMeta, as reported by Reuters, the shareholders of Aethlon Medical before the merger will hold approximately 4.75% of the shares in the merged company, while the shareholders of North Immunology will hold about 95.25% of the shares.
Bullish 0
Bearish 0
Source:Internet
This content is for market information only and does not constitute investment advice.